» Articles » PMID: 38534482

Endoscopic Hyperspectral Imaging System to Discriminate Tissue Characteristics in Tissue Phantom and Orthotopic Mouse Pancreatic Tumor Model

Overview
Date 2024 Mar 27
PMID 38534482
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we developed an endoscopic hyperspectral imaging (eHSI) system and evaluated its performance in analyzing tissues within tissue phantoms and orthotopic mouse pancreatic tumor models. Our custom-built eHSI system incorporated a liquid crystal tunable filter. To assess its tissue discrimination capabilities, we acquired images of tissue phantoms, distinguishing between fat and muscle regions. The system underwent supervised training using labeled samples, and this classification model was then applied to other tissue phantom images for evaluation. In the tissue phantom experiment, the eHSI effectively differentiated muscle from fat and background tissues. The precision scores regarding fat tissue classification were 98.3% for the support vector machine, 97.7% for the neural network, and 96.0% with a light gradient-boosting machine algorithm, respectively. Furthermore, we applied the eHSI system to identify tumors within an orthotopic mouse pancreatic tumor model. The F-score of each pancreatic tumor-bearing model reached 73.1% for the KPC tumor model and 63.1% for the Pan02 tumor models. The refined imaging conditions and optimization of the fine-tuning of classification algorithms enhance the versatility and diagnostic efficacy of eHSI in biomedical applications.

Citing Articles

Advancing hyperspectral imaging and machine learning tools toward clinical adoption in tissue diagnostics: A comprehensive review.

Lai C, Karmakar R, Mukundan A, Natarajan R, Lu S, Wang C APL Bioeng. 2024; 8(4):041504.

PMID: 39660034 PMC: 11629177. DOI: 10.1063/5.0240444.

References
1.
Wilson R, Chandra M, Scheiman J, Simeone D, McKenna B, Purdy J . Optical spectroscopy detects histological hallmarks of pancreatic cancer. Opt Express. 2009; 17(20):17502-16. DOI: 10.1364/OE.17.017502. View

2.
McCormack D, Walsh A, Sit W, Arteaga C, Chen J, Cook R . In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts. Biomed Opt Express. 2014; 5(7):2247-61. PMC: 4102362. DOI: 10.1364/BOE.5.002247. View

3.
Regeling B, Thies B, Gerstner A, Westermann S, Muller N, Bendix J . Hyperspectral Imaging Using Flexible Endoscopy for Laryngeal Cancer Detection. Sensors (Basel). 2016; 16(8). PMC: 5017453. DOI: 10.3390/s16081288. View

4.
Han Z, Zhang A, Wang X, Sun Z, Wang M, Xie T . In vivo use of hyperspectral imaging to develop a noncontact endoscopic diagnosis support system for malignant colorectal tumors. J Biomed Opt. 2016; 21(1):16001. DOI: 10.1117/1.JBO.21.1.016001. View

5.
Modir N, Shahedi M, Dormer J, Ma L, Ghaderi M, Sirsi S . LED-based Hyperspectral Endoscopic Imaging. Proc SPIE Int Soc Opt Eng. 2023; 11954. PMC: 9928531. DOI: 10.1117/12.2609023. View